Groton, MA, United States of America

Mike Weiser


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Mike Weiser from Groton, MA**

Introduction

Mike Weiser, an inventive mind hailing from Groton, Massachusetts, is recognized for his contribution to the field of medical technology. With a keen focus on enhancing therapeutic methodologies, Weiser has been at the forefront of innovation, aiming to improve patient outcomes through his inventive systems and methods.

Latest Patents

Weiser holds a patent for "Systems and methods for imbedded intramuscular implants." This groundbreaking invention introduces systems and methods designed to stimulate intramuscular angiogenesis by placing a biocompatible device within muscle tissue. The device is specifically dimensioned for optimal placement, allowing it to be inserted using techniques that are familiar to practitioners in the field. One of the notable applications of this invention involves the placement of the device within the myocardium, showcasing its potential in cardiac treatments.

Career Highlights

Weiser has made significant strides in his career, particularly through his association with C. R. Bard, Inc., a leading company in the medical technology industry. His work has not only developed a patented technology but has also contributed to the broader realm of implantable devices aimed at improving healing processes within muscle tissues.

Collaborations

Throughout his career, Weiser has had the opportunity to collaborate with esteemed colleagues, notably Richard A. Gambale and Stephen J. Forcucci. These collaborations have fostered a productive environment that encourages innovative thinking and the development of cutting-edge solutions in medical technology.

Conclusion

In conclusion, Mike Weiser stands out as a prominent figure in the landscape of medical inventions. His patent for systems and methods for imbedded intramuscular implants reflects a significant advancement in therapeutic technology. As he continues to work with C. R. Bard, Inc. and collaborates with others in his field, Weiser is sure to make further impactful contributions to healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…